Yijie Wu

585 citations
22 papers · 533 indexed · h-index 11

Yijie Wu

22 papers receiving 529 citations

Peers

Yijie Wu
Comparison fields: 5 of 106
  • Complementary and alternative medicine 70
  • Health, Toxicology and Mutagenesis 103
  • Molecular Biology 344
  • Pharmacology 43
  • Clinical Biochemistry 18
Replace Peiqiu Liao with:
Peiqiu Liao China
Dezhao Lu China
Sang Woon Chung South Korea
Gregory A. Barding United States
Hamid Ceylan Türkiye
Hari N. Bhilwade India
Caigao Zhong China
Jörg Flemmig Germany
S. Karkabounas Greece
Yijie Wu relative to Peiqiu Liao China Peiqiu Liao's profile →
Citations per field
00.5×3.7×
Peiqiu Liao · 1×
Citations per year

Countries citing papers authored by Yijie Wu

Since Specialization
Citations

This map shows the geographic impact of Yijie Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yijie Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yijie Wu more than expected).

Fields of papers citing papers by Yijie Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yijie Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yijie Wu. The network helps show where Yijie Wu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yijie Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yijie Wu Line = papers co-authored together Yijie Wu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20255
2 20256
3 20241
4 20175
5 20173
6 201513
7 20121
8 20119
9 200914
10 2008125
11 2007103
12 200746
13 200624
14 200615
15 200536
16 200541
17 200533
18 200433
19 19997
20 19978

About Yijie Wu

Yijie Wu is a scholar working on Clinical Biochemistry, Radiology, Nuclear Medicine and Imaging, Nuclear and High Energy Physics, Geriatrics and Gerontology and Molecular Biology, having authored 22 papers that have together received 533 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (12 papers), Advanced MRI Techniques and Applications (8 papers), NMR spectroscopy and applications (5 papers), Metabolism and Genetic Disorders (4 papers), Lanthanide and Transition Metal Complexes (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Diet and metabolism studies (2 papers) and Adipose Tissue and Metabolism (2 papers). The work is most often cited by research in Complementary and alternative medicine (70 citations), Health, Toxicology and Mutagenesis (103 citations), Molecular Biology (344 citations), Pharmacology (43 citations) and Clinical Biochemistry (18 citations). Yijie Wu has collaborated with scholars based in China. Frequent co-authors include Xiaojing Li, Fengkui Pei, Huifeng Wu, Peiqiu Liao, Weisheng Li, Lai Wei, Zhong‐Feng Li, Xiaoyu Zhang, Xiaoyu Zhang and Jiazuan Ni. Their work appears in journals such as Journal of Rare Earths, Analytical Biochemistry, Toxicology and Applied Pharmacology, OMICS A Journal of Integrative Biology and Journal of Inorganic Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026